Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer.

Alvarado MD, Mittendorf EA, Teshome M, Thompson AM, Bold RJ, Gittleman MA, Beitsch PD, Blair SL, Kivilaid K, Harmer QJ, Hunt KK.

Ann Surg Oncol. 2019 Oct;26(11):3510-3516. doi: 10.1245/s10434-019-07577-4. Epub 2019 Jul 11.

PMID:
31297674
2.

Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does not Provide Reliable Nodal Staging: Results from a Large Multicenter Trial.

Thompson JF, Haydu LE, Uren RF, Andtbacka RH, Zager JS, Beitsch PD, Agnese DM, Mozzillo N, Testori A, Bowles TL, Hoekstra HJ, Kelley MC, Sussman J, Schneebaum S, Smithers BM, McKinnon G, Hsueh E, Jacobs L, Schultz E, Reintgen D, Kane JM, Friedman EB, Wang H, Van Kreuningen L, Schiller V, Elashoff DA, Elashoff R, Cochran AJ, Stern S, Faries MB; MSLT-II Trial Group.

Ann Surg. 2019 Jun 7. doi: 10.1097/SLA.0000000000003405. [Epub ahead of print]

PMID:
31188198
3.

Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?

Beitsch PD, Whitworth PW, Hughes K, Patel R, Rosen B, Compagnoni G, Baron P, Simmons R, Smith LA, Grady I, Kinney M, Coomer C, Barbosa K, Holmes DR, Brown E, Gold L, Clark P, Riley L, Lyons S, Ruiz A, Kahn S, MacDonald H, Curcio L, Hardwick MK, Yang S, Esplin ED, Nussbaum RL.

J Clin Oncol. 2019 Feb 20;37(6):453-460. doi: 10.1200/JCO.18.01631. Epub 2018 Dec 7.

PMID:
30526229
4.

BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer.

Kwon MJ, Lee SB, Han J, Lee JE, Lee JW, Gong G, Beitsch PD, Nam SJ, Ahn SH, Nam BH, Shin YK.

PLoS One. 2018 Nov 21;13(11):e0207155. doi: 10.1371/journal.pone.0207155. eCollection 2018.

5.

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.

Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Morrow M.

JAMA. 2017 Sep 12;318(10):918-926. doi: 10.1001/jama.2017.11470.

6.

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.

Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, Jahkola T, Bowles TL, Testori A, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, Wouters MWJM, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Rossi CR, Neves RI, Trocha SD, Wright F, Byrd DR, Matter M, Hsueh E, MacKenzie-Ross A, Johnson DB, Terheyden P, Berger AC, Huston TL, Wayne JD, Smithers BM, Neuman HB, Schneebaum S, Gershenwald JE, Ariyan CE, Desai DC, Jacobs L, McMasters KM, Gesierich A, Hersey P, Bines SD, Kane JM, Barth RJ, McKinnon G, Farma JM, Schultz E, Vidal-Sicart S, Hoefer RA, Lewis JM, Scheri R, Kelley MC, Nieweg OE, Noyes RD, Hoon DSB, Wang HJ, Elashoff DA, Elashoff RM.

N Engl J Med. 2017 Jun 8;376(23):2211-2222. doi: 10.1056/NEJMoa1613210.

7.

Surgical Breast Specialists 2.0: Rethinking the Future of Breast Fellowship Training.

Beitsch PD, Whitworth P.

Ann Surg Oncol. 2016 Oct;23(11):3435-3437. doi: 10.1245/s10434-016-5345-6. Epub 2016 Jun 22. No abstract available.

PMID:
27334219
8.

Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Biopsy.

McMasters KM, Egger ME, Edwards MJ, Ross MI, Reintgen DS, Noyes RD, Martin RC 2nd, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Sussman JJ, Davidson BS, Gershenwald JE, Hagendoorn LJ, Stromberg AJ, Scoggins CR.

J Clin Oncol. 2016 Apr 1;34(10):1079-86. doi: 10.1200/JCO.2015.63.3776. Epub 2016 Feb 8.

9.

Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis.

Drukker CA, Elias SG, Nijenhuis MV, Wesseling J, Bartelink H, Elkhuizen P, Fowble B, Whitworth PW, Patel RR, de Snoo FA, van 't Veer LJ, Beitsch PD, Rutgers EJ.

Breast Cancer Res Treat. 2014 Dec;148(3):599-613. doi: 10.1007/s10549-014-3188-z. Epub 2014 Nov 21. Erratum in: Breast Cancer Res Treat. 2015 Jan;149(2):567.

PMID:
25414025
10.

Chemosensitivity predicted by BluePrint 80-gene functional subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST).

Whitworth P, Stork-Sloots L, de Snoo FA, Richards P, Rotkis M, Beatty J, Mislowsky A, Pellicane JV, Nguyen B, Lee L, Nash C, Gittleman M, Akbari S, Beitsch PD.

Ann Surg Oncol. 2014 Oct;21(10):3261-7. doi: 10.1245/s10434-014-3908-y. Epub 2014 Aug 7.

11.

American Society of Breast Surgeons presidential address: breast cancer surgery is dead…or is it?

Beitsch PD.

Ann Surg Oncol. 2014 Oct;21(10):3166. doi: 10.1245/s10434-014-3910-4. Epub 2014 Jul 22. No abstract available.

PMID:
25047473
12.

Can breast surgeons provide breast cancer genetic testing? An American Society of Breast Surgeons survey.

Beitsch PD, Whitworth PW.

Ann Surg Oncol. 2014 Dec;21(13):4104-8. doi: 10.1245/s10434-014-3711-9. Epub 2014 Apr 23.

PMID:
24756810
13.

Evaluation of current consensus statement recommendations for accelerated partial breast irradiation: a pooled analysis of William Beaumont Hospital and American Society of Breast Surgeon MammoSite Registry Trial Data.

Wilkinson JB, Beitsch PD, Shah C, Arthur D, Haffty BG, Wazer DE, Keisch M, Shaitelman SF, Lyden M, Chen PY, Vicini FA.

Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1179-85. doi: 10.1016/j.ijrobp.2012.10.010. Epub 2012 Nov 22.

PMID:
23182700
14.

Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial.

Hunt KK, Ballman KV, McCall LM, Boughey JC, Mittendorf EA, Cox CE, Whitworth PW, Beitsch PD, Leitch AM, Buchholz TA, Morrow MA, Giuliano AE.

Ann Surg. 2012 Sep;256(3):428-36.

15.

Tumor bed control with balloon-based accelerated partial breast irradiation: incidence of true recurrences versus elsewhere failures in the American Society of Breast Surgery MammoSite(®) Registry Trial.

Beitsch PD, Wilkinson JB, Vicini FA, Haffty B, Fine R, Whitworth P, Kuerer H, Zannis V, Lyden M.

Ann Surg Oncol. 2012 Oct;19(10):3165-70. doi: 10.1245/s10434-012-2489-x. Epub 2012 Jul 27.

PMID:
22836556
16.

Postsurgical treatment of early-stage breast cancer with electronic brachytherapy: outcomes and health-related quality of life at 1 year.

Patel RR, Beitsch PD, Nichols TD, Lorenzetti JD, Wurzer JC, Tucker JC, Nunn GW, Laduzinsky SJ, Kugler MA, Simmons DL, Gilligan MS, Roy T, Foley JK, Thropay JP, Odou MW, Bornstein BA, Tito EP, Chadha M, Boolbol SK, Lane SC, White JG.

Am J Clin Oncol. 2013 Oct;36(5):430-5. doi: 10.1097/COC.0b013e31825493bb.

PMID:
22706177
17.

Factors associated with optimal long-term cosmetic results in patients treated with accelerated partial breast irradiation using balloon-based brachytherapy.

Vicini FA, Keisch M, Shah C, Goyal S, Khan AJ, Beitsch PD, Lyden M, Haffty BG.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):512-8. doi: 10.1016/j.ijrobp.2011.07.011. Epub 2011 Nov 11.

PMID:
22079730
18.

Axillary failure in patients treated with MammoSite accelerated partial breast irradiation.

Aburabia M, Roses RE, Kuerer HM, Fine R, Beitsch PD, Goyal S, Haffty B, Lyden M, Vicini FA.

Ann Surg Oncol. 2011 Nov;18(12):3415-21. doi: 10.1245/s10434-011-1734-z. Epub 2011 May 3.

PMID:
21537870
19.

Ductal carcinoma in situ treated with breast-conserving surgery and accelerated partial breast irradiation: comparison of the Mammosite registry trial with intergroup study E5194.

Goyal S, Vicini F, Beitsch PD, Kuerer H, Keisch M, Motwani S, Jeruss JS, Lyden M, Haffty BG.

Cancer. 2011 Mar 15;117(6):1149-55. doi: 10.1002/cncr.25615. Epub 2010 Nov 2.

20.

Accelerated partial breast irradiation.

Beitsch PD, Shaitelman SF, Vicini FA.

J Surg Oncol. 2011 Mar 15;103(4):362-8. doi: 10.1002/jso.21785. Review.

PMID:
21337572
21.

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.

Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M.

JAMA. 2011 Feb 9;305(6):569-75. doi: 10.1001/jama.2011.90.

22.

A novel automated assay for the rapid identification of metastatic breast carcinoma in sentinel lymph nodes.

Feldman S, Krishnamurthy S, Gillanders W, Gittleman M, Beitsch PD, Young PR, Streck CJ, Whitworth PW, Levine EA, Boolbol S, Han LK, Hermann R, Hoon DS, Giuliano AE, Meric-Bernstam F; US One Step Nucleic Acid Amplification Clinical Study Group.

Cancer. 2011 Jun 15;117(12):2599-607. doi: 10.1002/cncr.25822. Epub 2011 Jan 11.

23.

Post-surgical treatment of early-stage breast cancer with electronic brachytherapy: an intersociety, multicenter brachytherapy trial.

Beitsch PD, Patel RR, Lorenzetti JD, Wurzer JC, Tucker JC, Laduzinsky SJ, Kugler MA.

Onco Targets Ther. 2010 Oct 29;3:211-8. doi: 10.2147/OTT.S14514.

24.

Controversies in breast surgery.

Boughey JC, Mittendorf EA, Solin LJ, Michael Dixon J, Tuttle TM, Beitsch PD, Cody HS, Leitch AM, Newman LA.

Ann Surg Oncol. 2010 Oct;17 Suppl 3:230-2. doi: 10.1245/s10434-010-1264-0. Epub 2010 Sep 19. No abstract available.

PMID:
20853038
25.

Update on DCIS outcomes from the American Society of Breast Surgeons accelerated partial breast irradiation registry trial.

Jeruss JS, Kuerer HM, Beitsch PD, Vicini FA, Keisch M.

Ann Surg Oncol. 2011 Jan;18(1):65-71. doi: 10.1245/s10434-010-1192-z. Epub 2010 Jun 25.

26.

Factors associated with false-negative sentinel lymph node biopsy in melanoma patients.

Scoggins CR, Martin RC, Ross MI, Edwards MJ, Reintgen DS, Urist MM, Gershenwald JE, Sussman JJ, Dirk Noyes R, Goydos JS, Beitsch PD, Ariyan S, Stromberg AJ, Hagendoorn LJ, McMasters KM.

Ann Surg Oncol. 2010 Mar;17(3):709-17. doi: 10.1245/s10434-009-0858-x. Epub 2009 Dec 5.

PMID:
19967459
27.

Attaining negative margins in breast-conservation operations: is there a consensus among breast surgeons?

Blair SL, Thompson K, Rococco J, Malcarne V, Beitsch PD, Ollila DW.

J Am Coll Surg. 2009 Nov;209(5):608-13. doi: 10.1016/j.jamcollsurg.2009.07.026. Epub 2009 Sep 11.

PMID:
19854401
28.

Factors associated with optimal cosmetic results at 36 months in patients treated with accelerated partial breast irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite Breast Brachytherapy Registry Trial.

Goyal S, Khan AJ, Vicini F, Beitsch PD, Lyden M, Keisch M, Haffty BG.

Ann Surg Oncol. 2009 Sep;16(9):2450-8. doi: 10.1245/s10434-009-0561-y. Epub 2009 Jun 11.

PMID:
19517191
29.

Four-year clinical update from the American Society of Breast Surgeons MammoSite brachytherapy trial.

Nelson JC, Beitsch PD, Vicini FA, Quiet CA, Garcia D, Snider HC, Gittleman MA, Zannis VJ, Whitworth PW, Fine RE, Keleher AJ, Kuerer HM.

Am J Surg. 2009 Jul;198(1):83-91. doi: 10.1016/j.amjsurg.2008.09.016. Epub 2009 Mar 6.

PMID:
19268900
30.

The surgeon's role in breast brachytherapy.

Beitsch PD, Hodge CW, Dowlat K, Francescatti D, Gittleman MA, Israel P, Nelson JC, Potruch T, Snider HC Jr, Whitworth P, Zannis VJ, Patel RR.

Breast J. 2009 Jan-Feb;15(1):93-100. doi: 10.1111/j.1524-4741.2008.00676.x.

PMID:
19141135
31.

Effect of multiple-nodal basin drainage on cutaneous melanoma.

Federico AC, Chagpar AB, Ross MI, Martin RC, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Sussman JJ, McMasters KM, Scoggins CR; Sunbelt Melanoma Trial.

Arch Surg. 2008 Jul;143(7):632-7; discussion 637-8. doi: 10.1001/archsurg.143.7.632.

PMID:
18645103
32.

Getting to better cancer care: results of a society of surgical oncology survey.

Wong SL, McCahill LE, Edge SB, Askew RL, Beitsch PD, Kollmorgen DR, Anthony T, Petrelli NJ, Leong SP, Cormier JN.

Ann Surg Oncol. 2008 Sep;15(9):2363-71. doi: 10.1245/s10434-008-9946-6. Epub 2008 May 10.

PMID:
18470568
33.

Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI).

Vicini F, Beitsch PD, Quiet CA, Keleher AJ, Garcia D, Snider HC Jr, Gittleman MA, Zannis VJ, Kuerer HM, Lyden M.

Cancer. 2008 Feb 15;112(4):758-66. doi: 10.1002/cncr.23227.

34.

Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis.

Chagpar RB, Ross MI, Reintgen DS, Edwards MJ, Scoggins CR, Martin RC 2nd, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Davidson BS, Sussman JJ, McMasters KM.

J Surg Res. 2007 Nov;143(1):164-8.

PMID:
17950088
35.

Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.

Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE; American College of Surgeons Oncology Group.

J Clin Oncol. 2007 Aug 20;25(24):3657-63. Epub 2007 May 7.

PMID:
17485711
36.

Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast.

Jeruss JS, Vicini FA, Beitsch PD, Haffty BG, Quiet CA, Zannis VJ, Keleher AJ, Garcia DM, Snider HC, Gittleman MA, Whitacre E, Whitworth PW, Fine RE, Arrambide S, Kuerer HM.

Ann Surg Oncol. 2006 Jul;13(7):967-76. Epub 2006 May 16.

PMID:
16788759
37.

Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.

Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Davidson BS, Sussman JJ, Edwards MJ, Martin RC, Lewis AM, Stromberg AJ, Conrad AJ, Hagendoorn L, Albrecht J, McMasters KM.

J Clin Oncol. 2006 Jun 20;24(18):2849-57.

PMID:
16782924
38.

Gender-related differences in outcome for melanoma patients.

Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Sussman JJ, Edwards MJ, Chagpar AB, Martin RC, Stromberg AJ, Hagendoorn L, McMasters KM; Sunbelt Melanoma Trial.

Ann Surg. 2006 May;243(5):693-8; discussion 698-700.

39.

Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer.

Posther KE, McCall LM, Blumencranz PW, Burak WE Jr, Beitsch PD, Hansen NM, Morrow M, Wilke LG, Herndon JE 2nd, Hunt KK, Giuliano AE.

Ann Surg. 2005 Oct;242(4):593-9; discussion 599-602.

40.

Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancer.

Leitch AM, Beitsch PD, McCall LM, Posther K, Newman LA, Herndon JE 2nd, Hunt KK, Giuliano AE.

Am J Surg. 2005 Oct;190(4):539-42.

PMID:
16164916
41.

First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial.

Vicini FA, Beitsch PD, Quiet CA, Keleher A, Garcia D, Snider HC, Gittleman MA, Zannis VJ, Kuerer H, Whitacre EB, Whitworth PW, Fine RE, Haffty BG, Arrambide LS.

Cancer. 2005 Sep 15;104(6):1138-48.

42.

Circulating tumor cells in patients with breast cancer dormancy.

Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF, Beitsch PD, Leitch M, Hoover S, Euhus D, Haley B, Morrison L, Fleming TP, Herlyn D, Terstappen LW, Fehm T, Tucker TF, Lane N, Wang J, Uhr JW.

Clin Cancer Res. 2004 Dec 15;10(24):8152-62.

44.
45.

Lessons learned from the Sunbelt Melanoma Trial.

McMasters KM, Noyes RD, Reintgen DS, Goydos JS, Beitsch PD, Davidson BS, Sussman JJ, Gershenwald JE, Ross MI; Sunbelt Melanoma Trial.

J Surg Oncol. 2004 Jul 1;86(4):212-23.

PMID:
15221928
46.

Interpretive disparity among pathologists in breast sentinel lymph node evaluation.

Roberts CA, Beitsch PD, Litz CE, Hilton DS, Ewing GE, Clifford E, Taylor W, Hapke MR, Babaian A, Khalid I, Hall JD, Lindberg G, Molberg K, Saboorian H.

Am J Surg. 2003 Oct;186(4):324-9.

PMID:
14553843
47.

Who are we and what do we think?

Beitsch PD, Lerner AG, Laidley AL, Tafra L, Edwards MJ.

Am J Surg. 2003 Oct;186(4):321-3.

PMID:
14553842
48.

Improved lymphatic mapping technique for breast cancer.

Beitsch PD, Clifford E, Whitworth P, Abarca A.

Breast J. 2001 Jul-Aug;7(4):219-23.

PMID:
11678798
49.

Breast Cancer Cells in the Blood: A Pilot Study.

Krag DN, Ashikaga T, Moss TJ, Kusminsky RE, Feldman S, Carp NZ, Moffat FL, Beitsch PD, Frazier TG, Gaskin TA, Shook JW, Harlow SP, Weaver DL.

Breast J. 1999 Nov;5(6):354-358.

PMID:
11348313
50.

Detection of carcinoma cells in the blood of breast cancer patients.

Beitsch PD, Clifford E.

Am J Surg. 2000 Dec;180(6):446-8; discussion 448-9.

PMID:
11182395

Supplemental Content

Loading ...
Support Center